as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
7.41%
Downside
0.06%
Upside
52 Week's Low
52 Week's High
58.60%
Downside
328.48%
Upside
Check Tonix Pharmaceuticals Holding Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$190.2M
EPS (TTM)
-10.3
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.06
Industry PE ratio
-1.6902868852459016
PEG Ratio
0EBITDA
-97.5M
Revenue (TTM)
10.3M
Profit Margin
0.00%
Return On Equity TTM
-64.99%
Track how Tonix Pharmaceuticals Holding Corp. P/E has moved over time to understand its valuation trends.
Tonix Pharmaceuticals Holding Corp. in the last 5 years
Lowest (-194.10x)
March 31, 2024
Industry (-1.69x)
February 7, 2026
Today (0.06x)
February 7, 2026
Highest (-0.64x)
March 31, 2025
Today’s Price to Earnings Ratio: 0.06x
Compare market cap, revenue, PE, and other key metrics of Tonix Pharmaceuticals Holding Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $190.2M | -100% | 0.06 | 0.00% | |
| BUY | $122.3B | 122.02% | 33.56 | 31.35% | |
| BUY | $47.7B | 98.75% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 57.42% | 18.28 | 32.13% |
The Tonix Pharmaceuticals Holding Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Tonix Pharmaceuticals Holding Corp. investment value today
Current value as on today
₹1,35,109
Returns
₹35,109
(+35.11%)
Returns from Tonix Pharmaceuticals Holding Corp. Stock
₹31,800 (+31.8%)
Dollar Returns*
₹3,309 (+3.31%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Tonix Pharmaceuticals Holding Corp.. Average target price of $67.67
Get share price movements and forecasts by analysts on Tonix Pharmaceuticals Holding Corp..
What analysts predicted
75.87%UPSIDE
Target Price
$67.67
Current Price
$16.33
Analyzed by
8 Analysts
Target
$67.67
Tonix Pharmaceuticals Holding Corp. target price $67.67, a slight upside of 75.87% compared to current price of $16.33. According to 8 analysts rating.
Search interest for Tonix Pharmaceuticals Holding Corp. Stock has increased by 95% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:95% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 1.99M → 3.29M (in $), with an average increase of 39.3% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 58.4% return, outperforming this stock by 26.5%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.1% return, outperforming this stock by 142.0%
Price Dip
![]()
In the last 6 months, TNXP stock has moved down by -65.2%
Profit Down
![]()
Netprofit is down for the last 3 quarters, -16.82M → -32.00M (in $), with an average decrease of 40.6% per quarter
| Organisation | Tonix Pharmaceuticals Holding Corp. |
| Headquarters | 26 Main Street, Chatham, NJ, United States, 07928 |
| Industry | Health Technology |
| CEO | Dr. Seth Lederman M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Darryl Rideout Ph.D. | Executive Vice President of Experimental Chemistry |
Dr. Sina Bavari Ph.D. | Executive Vice President of Infectious Disease Research & Development |
Mr. Thomas Englese M.B.A. | Executive Vice President of Commercial Operations |
Ms. Siobhan Fogarty B.Sc., M.Sc. | Chief Technical Officer |
Mr. Bradley Saenger CPA | CFO & Treasurer |
Mrs. Jessica Edgar Morris | Chief Operating Officer |
Dr. Gregory M. Sullivan M.D. | Chief Medical Officer & Secretary |
Ms. Irina Ishak | General Counsel |
Dr. Zeil Rosenberg M.D., M.P.H. | Executive Vice President of Medical |
Dr. Seth Lederman M.D. | Co-Founder, President, CEO & Chairman |
Tonix Pharmaceuticals Holding Corp. share price today is $16.33 as on at the close of the market. Tonix Pharmaceuticals Holding Corp. share today touched a day high of $16.34 and a low of $15.12.
Tonix Pharmaceuticals Holding Corp. share touched a 52 week high of $69.97 on and a 52 week low of $6.76 on . Tonix Pharmaceuticals Holding Corp. stock price today i.e. is closed at $16.33,which is 76.66% down from its 52 week high and 141.57% up from its 52 week low.
Tonix Pharmaceuticals Holding Corp. market capitalisation is $0.00T as on .
Indian investors can start investing in Tonix Pharmaceuticals Holding Corp. (TNXP) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Tonix Pharmaceuticals Holding Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Tonix Pharmaceuticals Holding Corp. share’s latest price of $16.33 as on February 7, 2026 at 2:29 am IST, you will get 0.6124 shares of Tonix Pharmaceuticals Holding Corp.. Learn more about
fractional shares .
Tonix Pharmaceuticals Holding Corp. stock has given -100% share price returns and 23.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?